As of 05/21/2025, Gujarat Themis Biosyn Limited's market capitalization has reached $414.24 M. According to our data, Gujarat Themis Biosyn Limited is the 14920th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
Gujarat Themis Biosyn Limited has seen its market value grow from ₹3.65 B to ₹35.51 B since 2020, representing a total increase of 873.80% and an annual compound growth rate (CAGR) of 68.00%.
Date
Market Cap
Change (%)
05/21/2025
₹35.51 B
12.08%
12/31/2024
₹33.28 B
78.59%
12/29/2023
₹18.64 B
65.76%
12/30/2022
₹11.24 B
62.3%
12/31/2021
₹6.93 B
89.96%
12/31/2020
₹3.65 B
Company Profile
Gujarat Themis Biosyn Limited was founded in 1981 in India.
on the National Stock Exchange of India.
With 159 employees, it focuses on and aims to drive innovation in Medicinal Chemicals and Botanical Products.
Frequently Asked Questions
As of 05/21/2025, Gujarat Themis Biosyn Limited (including the parent company, if applicable) has an estimated market capitalization of $414.24 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
Gujarat Themis Biosyn Limited global market capitalization ranking is approximately 14920 as of 05/21/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.